Content and Expectations of Consultations of Patients With Opioid Substitution Treatment Considered as Stabilized: Cross-Testimonials Doctors - Patients (MSOSuiStab)

Opioid Substitution Treatment Clinical Trial

— MSOSuiStab  

Official title:

Content and Expectations of Consultations of Patients With Opioid Substitution Treatment Considered as Stabilized: Cross-Testimonials Doctors - Patients (MSOSuiStab)

Clinical Trial Details — Status: Enrolling by invitation

Administrative data

• NCT number: NCT03390829
• Other study ID #: 2017-A01752-51
• Status: Enrolling by invitation
• Phase: N/A
• First received: October 19, 2017
• Last updated: December 29, 2017
• Start date: October 20, 2017
• Est. completion date: April 20, 2019

Study information

• Verified date: October 2017
• Source: University Hospital, Angers
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Consultations in general medical practice concerning the follow-up of the patients receiving opiate substitution treatments are not exceptional.

It is nowadays agreed that addictive pathology goes far beyond the issue of product dependence, in favor of a pathology in itself. Centered on problems of attachment, of framework, of trust. The implementation of the opiate substitution treatments and the lifting of the product dependence appears only as a preliminary to the background work with the patient ex-user of opiate.

Finally, the literature provides little information on the experience of general practitioners and their patients under opiate substitution treatments regarding follow-up consultations in the stability phase.

The objective of this work is therefore to study the feelings on follow-up consultations, general practitioners and their patients under opiate substitution treatments considered stabilized.

Recruitment information / eligibility

• Status: Enrolling by invitation
• Enrollment: 20
• Est. completion date: April 20, 2019
• Est. primary completion date: April 20, 2019
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• major people patients receiving opiate substitution treatments

Exclusion Criteria:

• considered unstabilized with opiate substitution treatments

Related Conditions & MeSH terms

• Opioid Substitution Treatment

Intervention

Other:
• semi-directed interviews
semi-directed interviews

Locations

Country	Name	City	State
France	Université Angers	Angers

Sponsors (1)

Lead Sponsor	Collaborator
University Hospital, Angers

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	assessment of feelings on follow-up consultations with standardized questionnaire		1 hour